CASI Pharma Cash Flow - Annual (NASDAQ:CASI)

Add to My Stocks
$3.27 $0.24 (6.84%) CASI stock closing price Oct 15, 2018 (Closing)

The CASI Pharma cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the CASI Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as CASI Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. CASI Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. CASI Pharma had cash and cash equivalents of $27.09M at the beginning of the year and $43.48M at year end for 2017. The cash from operating activities for CASI Pharma is $ 2017, which saw a decrease from previous year.

View details of CASI Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------0.25M
Net Increase (Decrease) in Assets Liabilities3.57M----1.29M-0.35M-0.27M-2.59M-0.05M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-3.01M1.58M21.88M2.04M11.01M-3.34M-3.45M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.93M-0.06M-0.02M-0.23M-0.04M-0.04M----0.13M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments--------7.5M10.97M
Other Cash Inflow (Outflow) from Investment Activities----0.23M------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares24.19M28.14M--10.84M-1.31M13.09M--
Issuance (Repayment) of Debt Securities-----10M-0.75M-8.55M-7.7M-2.98M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.46M-0.09M---0.44M-0.77M-0.16M-1M-0.01M-0.07M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year27.09M5.13M10.66M15.13M8.04M1.08M4.88M6.31M16.74M29.67M
Cash & Equivalents at Year End43.48M27.09M5.13M10.66M15.13M8.04M1.08M4.88M6.31M16.74M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

CASI Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of CASI Pharma stock price history.
The statement of cash flows can be categorized into three main sections:

  • CASI Pharma saw a negative change in Net Change in Cash and Cash Equivalents of $16.39M in 2017. Apart from the CASI Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. CASI Pharma lost $-6.4M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.93M for CASI in last 2017 report.
  • Cash flow from financing activities shows the flow of cash between CASI Pharma and its owners and creditors and was $23.73M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For CASI Pharma Cash Flow